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Figure 1. Sagittal endovaginal ultrasound in a case of endometriosis showing 
moderately echogenic nodule (arrows) with irregular margins lying posterior to 
the cervix and infiltrating/obliterating the Pouch of Douglas.
Figure 2. Coronal endovaginal ultrasound scan through the cervix in a case of 
endometriosis showing a hypoechoic mass centred in the Pouch of Douglas 
infiltrating the cervix posterolateral to the endocervical canal (*). 
endometriosis, a benign gynaecologic disorder that affects approximately 10% of women of reproductive age, is defined as endometrial tissue outside the uterus. Cervical 
involvement with endometriosis is rare occurring in 0.1%–2.4% 
of patients. Cervical endometriosis may be superficial or deep 
depending on the depth of penetration of the cervix. The 
pathogenesis of cervical endometriosis is unknown. Superficial 
cervical endometriosis may be an incidentally detected 
histologic finding in asymptomatic women. It may also manifest 
as a cervical mass, with symptoms of pelvic pain or abnormal 
vaginal bleeding. On ultrasound, cervical endometriosis may 
present as a complex cystic mass within the endocervical canal, 
but may even appear solid extending into the paracervical 
tissues. In the latter case, it could mimic leiomyomas, polyps, 
and even carcinoma. Although clinical history and speculum 
exam may suggest the diagnosis, biopsy confirmation is 
required.
Endometriosis usually presents through symptoms related 
to peritoneal infiltration, which may be superficial or deep 
(extending >5mm below the peritoneal surface). Deep infiltrating 
peritoneal lesions located in the Pouch of Douglas (Fig 1) may 
penetrate the posterior aspect of the cervix. External cervical 
penetration from an endometriotic lesion in the Pouch of Douglas 
would appear as a hypoechoic mass infiltration the posterior 
cervical stroma on ultrasound, and would mimic peritoneal 
carcinomatosis or invasive cervical cancer (Fig 2). 
MR imaging may help to establish the correct diagnosis by 
showing the characteristic low T2 signal intensity resulting from 
haemosiderin deposition with high T1 signal foci representing 
fresh haemorrhage (Fig 3).
Cervical cancer is the leading gynecologic cancer worldwide. 
There are multiple known risk factors for development of cervical 
cancer, including history of multiple sexual partners, early age 
of first intercourse, multiparity, lower socioeconomic standing, 
cigarette smoking, immunosuppressed state, and use of oral 
contraceptives. There is also a strong association with human 
papillomavirus (serotypes 16, 18, 31, 33, and 56) accounting for 
more than 80% of all invasive cervical cancers. The increasing use 
of the human papillomavirus vaccine appears to be leading to a 
significant decrease in the incidence of cervical cancer.
The mucosal lining of the cervix is composed of columnar 
cells in its proximal portion and squamous epithelial cells 
more distally. The transition zone is the border that separates 
the proximal columnar lined cervical canal from the distal 
squamous cell lined portion. The transition zone lies more 
distally in younger women (20-40 years of age) and moves more 
proximally with increasing age. The transition zone is the site 
of development of cervical cancer. Thus cervical cancer tends 
to be closer to the external os and is more exophytic in younger 
women, while in older women it lies closer to the internal os and 
is more endophytic. 80-90% of cervical cancers are squamous 
cell cancers, while 5-20% (depending on published source) are 
adenocarcinomas. 
Women with cervical cancer tend to present with abnormal 
vaginal bleeding mainly intermenstrual bleeding (metrorrhagia) 
and post-menopausal bleeding. Cervical cancer can also lead to 
cervical canal stenosis and obstruction resulting in hydrometra, 
haematometra and pyometra. 
Accurate staging of cervical cancer is critical for proper 
management, because risk stratification and mode of treatment 
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This article follows on Part I, which appeared in the last issue of The Synapse Journal. It will 
discuss imaging of endometriosis in the cervical canal and also cervical cancer. The importance 
of imaging in staging of cervical cancer will be stressed.
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Figure 3. Sagittal T2-w MR image in a case of endometriosis showing an ill-
defined mass (arrows) infiltrating the posterior wall of the uterus and cervix and 
the anterior wall of the rectum. The mass contains hypointense foci (curved arrow) 
due to haemosiderin content and hyperintense foci (arrowhead) due blood. A 
hyperintense mass (E) seen superior to the uterus represents an endometrioma. 
Figure 4. FIGO staging of cervical cancer. 
radiology
depend on tumour size, the presence and extent of local invasion 
and the presence of metastases. Traditionally, staging of cervical 
cancer was performed through clinical examination using the 
FIGO (International Federation of Gynaecology and Obstetrics) 
staging system (Fig 4). MR imaging provides a more accurate 
method of the stage of cervical cancer than clinical examination. 
Thus FIGO staging is now based on MR imaging findings rather 
than clinical examination. Endovaginal ultrasound is used mainly 
for detection of cervical cancer. 
Tumours restricted to the uterus and upper two thirds of 
the vagina and <4cm in size (Stage IIa or lower) are amenable 
to surgery. Tumours >4cm in size, involving the distal third of 
the vagina or extending to the parametrium, pelvic sidewall, 
rectum or bladder (Stage IIb and higher) are best treated with 
radiotherapy and chemotherapy. Tumours <2cm in diameter 
(Stage 1A2 and 1B1) may be treated with fertility sparing surgery 
if the remaining cervix is >1cm in length. 
Early cervical cancer is difficult to detect on ultrasound 
due to its small size and similar echotexture to normal cervical 
mucosa. However, published data has shown that up to 93% of 
invasive cervical cancer is detected by endovaginal ultrasound. 
Ultrasound features of cervical cancer include abnormal 
mucosal echotexture, distortion of cervical morphology and 
loss of compressibility of the cervix. Cervical cancer also shows 
increased vascularity on Doppler ultrasound in almost all 
cases (Fig 5). Occasionally the cervix may be totally replaced 
by tumour and invasion of adjacent organs may be evident on 
Figure 5. Sagittal endovaginal ultrasound showing a cervical cancer (arrows) that 
is causing distortion of cervical canal architecture and abnormal echotexture and 
demonstrates hypervascularity on colour Doppler evaluation.
Figure 6. Sagittal endovaginal ultrasound of a locally advanced cervical cancer 
(M) showing invasion of the bladder wall (arrow). A normal segment of bladder 
wall (arrowhead) is also seen.
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endovaginal ultrasound (Fig 6). Application of pressure on the 
endovaginal probe evaluates mobility of the cervix in relation 
to the rectum, bladder and vagina; lack of mobility indicates 
adjacent organ involvement. 
MR imaging provides accurate evaluation of cervical tumour 
size and invasion of adjacent structures including the bladder, 
rectum and parametrial regions (Figs 7-9). Evaluation of the 
retroperitoneum is required particularly in case of larger tumours 
to detect lymph node metastases and ureteric infiltration with 
obstruction; this may be performed with computed tomography 
(CT) or MR imaging. 
Occasionally, a mass in the cervix may be due to inferior 
extension of an endometrial cancer (Fig 10). This condition may 
be detected on both endovaginal ultrasound and MR imaging, 
and its distinction is of clinical relevance as the treatment options 
for the cervical and endometrial cancer differ. 
It is important to note that a number of pitfalls exist in relation 
to ultrasound assessment of cervical cancer. It is common to see 
a relative lack of images of the cervix in pelvic ultrasound exams. 
Failure to visualise and document a normal cervix may lead to 
missed cervical cancer. An inability to visualise and document 
a normal cervix may occasionally be the only indicator of 
disease in the cervix. A mass in a grossly distorted cervix may 
be erroneously interpreted as a uterine fibroid if a normal cervix 
has not been properly documented. Hydrometra should also be 
interpreted with caution as obstruction of the cervical canal may 
be due to a cervical cancer. In cases where ultrasound does not 
clearly document a normal cervix, where secondary signs are 
present (e.g. haematometra) or clinical symptoms are persistent 
and unexplained, it is prudent to proceed to MR imaging.  
Figure 7. Coronal endovaginal Doppler ultrasound showing a hypervascular tumour 
with parametrial invasion (arrow) and obstruction of the left ureter (arrowhead).
Figure 10a. Sagittal endovaginal ultrasound showing an ill-defined mass in the 
cervix (arrows). 
Figure 8. Sagittal T2-weighted image 
showing a cervical mass (arrow) of 
mixed hyperintensity that involves all 
of the cervical canal and extends into 
the lower uterus, but does not involve 
the outer stromal layer, vagina or 
adjacent organs. A fibroid (*) is 
incidentally noted. 
Figure 9. Sagittal T2-weighted 
image showing an extensive mass 
(arrowheads) originating from the 
cervix and involving the uterus and 
rectum. Extension into the bladder 
(arrow) is also noted.
Figure 10b. Sagittal endovaginal ultrasound showing a mass in the endometrial 
cavity of the uterus (arrows). c. Sagittal T2-weighted MR scan depicting a 
large mass (arrowheads) extending from the uterine cavity into the cervix and 
vagina (arrow). 
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